Skip to search formSkip to main contentSkip to account menu

risedronate sodium 30 MG Oral Tablet

Known as: RISEDRONATE SODIUM HEMI-PENTAHYDRATE 25.8 mg / RISEDRONATE SODIUM MONOHYDRATE 4.2 mg ORAL TABLET, FILM COATED, RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30 mg ORAL TABLET, FILM COATED, RISEDRONATE NA 30MG TAB [VA Product] 
National Institutes of Health

Related topics

Related topics

31 relations
CroscarmelloseCrospovidoneDiphosphonatesDrug Allergy

Broader (1)

HORMONES/SYNTHETICS/MODIFIERS,OTHER

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Risedronate による食道潰瘍の1 例―食道裂孔ヘルニアとの関連について―
Bisphosphonates can cause chemical ulcerations in the esophagus in some patients. The postulated pathophysiological mechanism of… 
2006
2006
Methode amelioree de preparation de risedronate sodique cristallin
L'invention concerne une nouvelle methode de preparation de risedronate sodique cristallin, mise en oeuvre dans des conditions… 
2005
2005
GnRH agonist 療法施行時の risedronate 併用投与における服薬コンプライアンスに関する検討(その他VI, 第57回日本産科婦人科学会学術講演会)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)